Compare BIO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | HSIC |
|---|---|---|
| Founded | 1952 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.1B |
| IPO Year | N/A | 1995 |
| Metric | BIO | HSIC |
|---|---|---|
| Price | $312.40 | $78.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 14 |
| Target Price | ★ $358.50 | $76.29 |
| AVG Volume (30 Days) | 184.0K | ★ 1.2M |
| Earning Date | 02-12-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | N/A | ★ 3.17 |
| Revenue | $2,557,500,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $1.62 | $5.34 |
| Revenue Next Year | $2.26 | $3.42 |
| P/E Ratio | ★ N/A | $24.53 |
| Revenue Growth | N/A | ★ 3.51 |
| 52 Week Low | $211.43 | $60.56 |
| 52 Week High | $373.69 | $82.49 |
| Indicator | BIO | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 57.81 |
| Support Level | $306.52 | $77.53 |
| Resistance Level | $328.56 | $79.97 |
| Average True Range (ATR) | 9.16 | 2.08 |
| MACD | -0.38 | -0.05 |
| Stochastic Oscillator | 40.11 | 78.02 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.